Crysvita

Generic name: Burosumab
Drug class: Miscellaneous metabolic agents

Usage of Crysvita

Crysvita is a monoclonal antibody that targets and blocks the activity of a blood protein called FGF23. In a genetic condition called X-linked hypophosphatemia (HYE-poe-fos-fa-TEEM-ee-a), low phosphate levels in blood are caused by abnormally high levels of FGF23 protein, which causes the kidneys to stop reabsorbing phosphate into the bloodstream.

Blocking the FGF23 protein allows the kidneys to restore and maintain normal phosphate levels. Phosphate is important for the strength of your bones and teeth. Low phosphate levels can lead to bone deformities and growth problems.

Crysvita is used to normalize phosphate levels in adults and children who are at least 1 year old and have X-linked hypophosphatemia.

Crysvita may also be used for purposes not listed in this medication guide.

Crysvita side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Common side effects of Crysvita may include:

headache, dizziness;

pain in your arms, legs, or back;

vomiting, constipation;

a restless feeling in your legs;

fever;

tooth infection;

decreased vitamin D levels;

increased phosphorous levels; or

pain, redness, itching, swelling, bruising, or a hard lump where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Crysvita

You should not use Crysvita if you are allergic to it, or if you have:

severe or end-stage kidney disease; or

if you currently take phosphate or vitamin D by mouth.

Tell your doctor if you have ever had:

kidney disease; or

restless leg syndrome.

It is not known whether Crysvita will harm an unborn baby. Tell your doctor if you are pregnant or if you become pregnant while using Crysvita.

It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.

Crysvita is not approved for use by anyone younger than 1 year old.

Relate drugs

How to use Crysvita

Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using Crysvita.

At least 1 week before your first injection, stop using oral phosphate and vitamin D medications.

Crysvita is injected under the skin, once every 2 weeks in children and once every 4 weeks in adults.

A healthcare provider will give you this injection.

Crysvita doses are based on weight in children. Your child's dose needs may change if the child gains or loses weight.

You may need frequent medical tests. Even if you have no symptoms, tests can help your doctor determine if this medicine is effective.

Warnings

You should not use Crysvita if you have severe kidney disease, or if you currently take phosphate or vitamin D by mouth.

What other drugs will affect Crysvita

Other drugs may affect Crysvita, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.